Abstract

Novel Therapeutic Approaches for Mitigating Complications in Short Bowel Syndrome

Nutrients. 2022 Nov 4;14(21):4660. doi: 10.3390/nu14214660.

 

Jeffery Bettag 1Loren Po 1Cassius Cunningham 1Rahul Tallam 1Kento Kurashima 1Aakash Nagarapu 1Chelsea Hutchinson 2Sylvia Morfin 1Mustafa Nazzal 2Chien-Jung Lin 1Amit Mathur 1Rajeev Aurora 1Ajay K Jain 1

 
     

Author information

1Department of Pediatrics, Saint Louis University School of Medicine, Saint Louis, MO 63103, USA.

2Department of Surgery, Saint Louis University School of Medicine, Saint Louis, MO 63103, USA.

Abstract

Short bowel syndrome (SBS) is a particularly serious condition in which the small intestine does not absorb sufficient nutrients for biological needs, resulting in severe illness and potentially death if not treated. Given the important role of the gut in many signaling cascades throughout the body, SBS results in disruption of many pathways and imbalances in various hormones. Due to the inability to meet sufficient nutritional needs, an intravenous form of nutrition, total parental nutrition (TPN), is administered. However, TPN presents difficulties such as severe liver injury and altered signaling secondary to the continued lack of luminal contents. This manuscript aims to summarize relevant studies into the systemic effects of TPN on systems such as the gut-brain, gut-lung, and gut-liver axis, as well as present novel therapeutics currently under use or investigation as mitigation strategies for TPN induced injury.

 

 

© Copyright 2013-2025 GI Health Foundation. All rights reserved.
This site is maintained as an educational resource for US healthcare providers only. Use of this website is governed by the GIHF terms of use and privacy statement.